メタボリック再プログラムと免疫センセンス: グリオマ治療の新たな視野

Huali Fan^1,2, Shizhuo Yang^1,2, Qing Lu^1,2

¹Department of Pharmacy, West China Tianfu Hospital, Sichuan University, Chengdu, China.

Frontiers in cell and developmental biology

|February 13, 2026

まとめ

グリオマの治療は,腫瘍の微小環境による課題に直面しています. この研究では,代謝再プログラムと免疫発現が膠原腫の進行と治療抵抗にどのように影響し,潜在的な治療戦略を提供するかを調査しています.

科学分野:

神経腫瘍学神経腫瘍学
がん免疫学がん免疫学
代謝経路について

背景:

膠原腫は,予後が悪い,再発率が高い中枢神経系腫瘍である.
膠原腫の微環境は免疫抑制性であり,効果的な免疫療法を阻害します.
メタボリック再プログラムと免疫発現は,膠原腫の進行と治療抵抗性の主要な特徴です.

研究の目的:

膠原腫における代謝再プログラミングの重要性と機能を実証する.
膠原腫の病原性における免疫発現の役割を明らかにする.
これらのメカニズムを標的とした有望な治療戦略の証拠を提供すること.

主な方法:

グリオマの代謝と免疫発現に関する現在の文献のレビュー.
主な代謝変化 (ウォーバーグ効果,グルタミン依存,PPP,脂質代謝) の分析.
免疫センセンス成分 (免疫不調,SASP,表遺伝的変化) の検査.

主要な成果:

メタボリック再プログラミングは,膠原腫の進行と治療抵抗を促します.
免疫セネセンスは,免疫細胞の機能障害と免疫抑制性マイクロ環境に貢献します.
衰老する免疫細胞と代謝微環境の間には相互作用があり,その逆もそうです.

結論:

メタボリック再プログラムと免疫発現は,膠原腫の重要な要因です.
これらのプロセスを理解することは,新しい膠原腫治療の開発に不可欠です.
代謝経路と免疫経路をターゲットにすることで,膠原腫の治療結果を改善する見込みがある.

キーワード:

エピジェネティック・レグレーショングリオマ・グリオマとは免疫性の発現を意味する.メタボリックリプログラミング腫瘍のマイクロ環境

さらに関連する動画

10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

7.1K

11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.9K

関連する概念動画

01:29

Sight Distance in a Vertical Curve

404

Sight distance on vertical curves is critical in roadway design. It ensures drivers can see far enough ahead to identify and respond to hazards effectively. This directly impacts safety, driver comfort, and the overall efficiency of the transportation network.Vertical curves are classified into crest and sag curves based on their geometry. For crest curves, sight distance is determined by the line of sight between a driver's eye and a small object on the road's surface. Design parameters for...

What is Metabolism?

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

27.7K

01:14

Introduction to Nuclear Reprogramming

2.3K

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...

2.3K

01:24

Methods of Nuclear Reprogramming

2.2K

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

2.2K

01:36

Carbohydrate Metabolism

14.4K

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...